Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 2, 2013, Pages 249-257

  Bernards, Daniel A ^a   Bhisitkul, Robert B ^b   Wynn, Paula ^b   Steedman, Mark R ^c   Lee, On Tat ^b   Wong, Fergus ^b   Thoongsuwan, Somanus ^b   Desai, Tejal A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UC Berkeley Graduate Group in Bioengineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCAPROLACTONE;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CATARACTOGENESIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORNEA EDEMA; DRUG DELIVERY SYSTEM; DRUG TOLERANCE; EYE INFLAMMATION; FEMALE; HISTOLOGY; MORPHOLOGY; NANOPORE; NONHUMAN; OCULAR FIBROSIS; POSTOPERATIVE COMPLICATION; RABBIT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; BIOCOMPATIBLE MATERIALS; EYE; FEMALE; MATERIALS TESTING; MICROSPHERES; NANOSTRUCTURES; POLYESTERS; RABBITS;

EID: 84875020562     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0152     Document Type: Article

References (37)

1. Lee, S.S., Hughes, P., Ross, A.D., & Robinson, M.R. Biodegradable implants for sustained drug release in the eye. Pharm. Res. 27:2043-2053, 2010.
2. Mohammad, D.A., Sweet, B.V., & Elner, S.G. Retisert: is the new advance in treatment of uveitis a good one? Ann. Pharmacother. 41:449-454, 2007.
3. Lee, S.S., Hughes, P.M., & Robinson, M.R. Recent advances in drug delivery systems for treating ocular complications of systemic diseases. Curr. Opin. Ophthalmol. 20: 511-519, 2009.
4. Jain, R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 21:2475-2490, 2000.
5. Kawaguchi, H. Functional polymer microspheres. Prog. Polym. Sci. 25:1171-1210, 2000.
6. Ravi Kumar, M.N. Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. 3:234-258, 2000.
7. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., and Rudzinski, W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release. 70:1-20, 2001.
8. Conti, B., Pavanetto, F., & Genta, I. Use of polylactic acid for the preparation of microparticulate drug delivery systems. J. Microencapsul. 9:153-166, 1992.
9. Lassalle, V., & Ferreira, M.L. PLA nano-And microparticles for drug delivery: an overview of the methods of preparation. Macromol. Biosci. 7:767-783, 2007.
10. Allison, S.D. Analysis of initial burst in PLGA microparticles. Expert Opin. Drug Deliv. 5:615-628, 2008.
11. Giteau, A., Venier-Julienne, M.C., Aubert-Pouëssel, A., and Benoit, J.P. How to achieve sustained and complete protein release from PLGA-based microparticles? Int. J. Pharm. 350:14-26, 2008.
12. Wischke, C., & Schwendeman, S.P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 364:298-327, 2008.
13. Aishwarya, S., Mahalakshmi, S., & Sehgal, P.K. Collagencoated polycaprolactone microparticles as a controlled drug delivery system. J. Microencapsul. 25:298-306, 2008.
14. Luciani, A., Coccoli, V., Orsi, S., Ambrosio, L., & Netti, P.A. PCL microspheres based functional scaffolds by bottom-up approach with predefined microstructural properties and release profiles. Biomaterials. 29:4800-4807, 2008.
15. Wei, X., Gong, C., Gou, M., et al. Biodegradable poly (epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharm. 381:1-18, 2009.
16. Budhian, A., Siegel, S.J., & Winey, K.I. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int. J. Pharm. 346:151-159, 2008.
17. Wei, X., Gong, C., Shi, S., et al. Self-Assembled honokiolloaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon- caprolactone) copolymer. Int. J. Pharm. 369:170-175, 2009.
18. Loftsson, T., Hreinsdóttir, D., & Stefánsson, E. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. J. Pharm. Pharmacol. 59:629-635, 2007.
19. Kompella, U.B., Bandi, N., & Ayalasomayajula, S.P. Subconjunctival nano-And microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest. Ophthalmol. Vis. Sci. 44:1192-1201, 2003.
20. Carcaboso, A.M., Chiappetta, D.A., Opezzo JAW, et al. Episcleral implants for topotecan delivery to the posterior segment of the eye. Invest. Ophthalmol. Vis. Sci. 51:2126-2134, 2010.
21. Labet, M., & Thielemans, W. Synthesis of polycaprolactone: a review. Chem. Soc. Rev. 38:3484-3504, 2009.
22. Kashanian, S., Harding, F., Irani, Y., et al. Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implants. Acta Biomaterialia. 6:3566-3572, 2010.
23. Redenti, S., Tao, S., Yang, J., et al. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold. J. Ocul. Biol. Dis. Inform. 1:19-29, 2008.
24. Steedman, M.R., Tao, S.L., Klassen, H., & Desai, T.A. Enhanced differentiation of retinal progenitor cells using microfabricated topographical cues. Biomed. Microdevices. 12:363-369, 2010.
25. Sodha, S., Wall, K., Redenti, S., Klassen, H., Young, M.J., and Tao, S.L. Microfabrication of a three-dimensional polycaprolactone thin-film scaffold for retinal progenitor cell encapsulation. J. Biomater. Sci. Polym. Ed. 22:443-456, 2011.
26. Christiansen, A.T., Tao, S.L., Smith, M., et al. Subretinal implantation of electrospun, short nanowire, and smooth poly(e-caprolactone) scaffolds to the subretinal space of porcine eyes. Stem Cells Int. 2012:454295, 2012.
27. Beeley, N.R.F., Rossi, J.V., Mello-Filho, P.A.A., et al. Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant. J. Biomed. Mater. Res.Part A. 73A:437-444, 2005.
28. Zarbin, M.A., Montemagno, C., Leary, J.F., & Ritch, R. Nanomedicine in ophthalmology: the new frontier. Am. J. Ophthalmol. 150:144-162, 2010.
29. Bernards, D.A., & Desai, T.A. Nanoscale porosity in polymer films: fabrication and therapeutic applications. Soft Matter. 6:1621-1631, 2010.
30. Jeon, G., Yang, S.Y., & Kim, J.K. Functional nanoporous membranes for drug delivery. J. Mater. Chem. 22:14814-14834, 2012.
31. Edelhauser, H.F., Rowe-Rendleman, C.L., Robinson, M.R., et al. Ophthalmic Drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest. Ophthalmol. Vis. Sci. 51:5403-5420, 2010.
32. Ainslie, K.M., Tao, S.L., Popat, K.C., et al. In vitro inflammatory response of nanostructured titania, silicon oxide, and polycaprolactone. J. Biomed. Mater. Res. Part A. 91A:647-655, 2009.
33. Bernards, D.A., & Desai, T.A. Nanotemplating of biodegradable polymer membranes for constant-rate drug delivery. Adv. Mater. 22:2358-2362, 2010.
34. Wang, C.H., Wong, A.S.W., & Ho, G.W. Facile solution route to vertically aligned, selective growth of ZnO nanostructure arrays. Langmuir. 23:11960-11963, 2007.
35. Silva-Cunha, A., Fialho, S.L., Naud M-C, and Behar-Cohen, F. Poly-epsilon-caprolactone intravitreous devices: an in vivo study. Invest. Ophthalmol. Vis. Sci. 50:2312-2318, 2009.
36. Natu, M.V., Gaspar, M.N., Fontes Ribeiro, C.A., Cabrita, A.M., de Sousa, H.C., & Gil, M.H. In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment. Int. J. Pharm. 415:73-82, 2011.
37. Fialho, S.L., Behar-Cohen, F., & Silva-Cunha, A. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study. Eur. J. Pharm. Biopharm. 68:637-646, 2008.